CUE - Cue Biopharma

-

$undefined

N/A

(N/A)

Cue Biopharma NASDAQ:CUE Cue Biopharma, a clinical-stage biopharmaceutical company, is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells directly within the patient's body to transform the treatment of cancer, infectious diseases and autoimmune diseases. The company's proprietary platform, Immuno-STAT ™(Selective Targeting and Alteration of T cells) is designed to harness the body's intrinsic immune system without the need for ex vivo manipulation.

Location: 21 Erie St, Massachusetts, 02139-4260, US | Website: www.cuebiopharma.com | Industry: Research and Development in Biotechnology | Sector: Professional, Scientific, and Technical Services


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

41.79M

Cash

30.03M

Avg Qtr Burn

-9.633M

Short % of Float

3.69%

Insider Ownership

0.55%

Institutional Own.

23.60%

Qtr Updated

06/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.